Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 426.00
+0.65 (0.15%)
Jul 31, 2026, 3:30 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 689.42 billion as of July 31, 2026. Its market cap has increased by 30.04% in one year.
Market Cap
689.42B
Enterprise Value
830.83B
Revenue
169.27B
Ranking
n/a
PE Ratio
150.96
Stock Price
426.00
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 689.42B, an increase of 1,418.12%. That is a compound annual growth rate of 12.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 689.42B | 31.16% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 444.92B |
| OneSource Specialty Pharma | 200.60B |
| Concord Biotech | 139.18B |
| Blue Jet Healthcare | 114.09B |
| Supriya Lifescience | 69.18B |
| Zota Health Care | 42.44B |
| Dishman Carbogen Amcis | 29.47B |
| Panacea Biotec | 25.96B |